Four different footprinting techniques have been used to probe the DNA sequence selectivity of Thia-Net, a bis-cationic analogue of the minor groove binder netropsin in which the N-methylpyrrole moieties are replaced by thiazole groups. In Thia-Net the ring nitrogen atoms are directed into the minor groove where they could accept hydrogen bonds from the exocyclic 2-amino group of guanine. Three nucleases (DNAase I, DNAase II, and micrococcal nuclease) were employed to detect binding sites on the 160bp tyr T fragment obtained from plasmid pKMA-98, and further experiments were performed with 117mer and 253mer fragments cut out of the plasmid pBS. MPE • Fe(ll) was used to footprint binding sites on an EcoR\/Hindll\ fragment from pBR322. Thia-Net binds to sites in the minor groove containing 4 or 5 base pairs which are predominantly composed of alternating A and T residues, but with significant acceptance of intrusive GC base pairs. Unlike the parent antibiotic netropsin, Thia-Net discriminates against homooligomeric runs of A and T. The evident preference of Thia-Net for AT-rich sites, despite its containing thiazole nitrogens capable of accepting GC sites by hydrogen bonding, supports the view that the biscationic nature of the ligand imposes a bias due to the electrostatic potential differences in the receptor which favour the ligand reading alternating AT sequences.
INTRODUCTION
Sequence-specific molecular recognition of DNA by proteins is central to the regulation of many cellular processes (1, 2) . Examination of the interaction between oligopeptides and DNA can be useful as a means of elucidating the structural basis for such selectivity. Moreover, studies of the interaction of oligopeptides with DNA have become increasingly important for the development of a rational approach to the design of new chemotherapeutic agents which interact at the gene level (3) .
Netropsin (1) and distamycin, natural oligopeptide antibiotics (4) have proved useful as models for such sequence selectivity. They bind exclusively to AT-rich sequences in the minor groove of double stranded DNA (5-7) and interfere with replication and transcription processes. The development of lexitropsins (8) , or information-reading molecules based on these oligopeptide antibiotics, revealed several factors which contribute to the molecular recognition process including (i) the ability of certain hydrogen bond-accepting heterocyclic moieties to mediate specific base pair recognition, (ii) the influence of ligand cationic charge in sequence selective binding, (iii) the role of van der Waals contacts in 3'-terminal base pair recognition, and (iv) base site avoidance as a means of controlling sequence recognition (9) (10) (11) (12) (13) (14) . To explore further factor (i) above we now describe studies on Thia-Net, 2 ( Fig. 1 ) a synthetic analogue of netropsin (1) in the structure of which the pyrrole rings of 1 are replaced by thiazole moieties and the amidine and guanidine by propanamidinium groups (15) .
Although footprinting has proved very informative concerning sequence recognition by DNA binding ligands, the results can depend on the type of cleaving agent employed. Ideally, the probe should be insensitive to DNA structure and should possess no sequence specificity. Two categories of cutting probes are commonly used, (i) enzymes, typified by DNAase I, which are very sensitive and produce easily recognisable binding sites, (ii) metal complexes, typified by EDTA-Fe, which possess very little sequence specificity and allow more accurate measurement of the drug binding site size. On the negative side, enzymatic probes exhibit a more or less pronounced sequence selectivity of cleavage and produce cleavage inhibition regions larger than the actual binding site. Metal chelates, which generate highly reactive radical species, produce extensive DNA-cleavage products leading to discrete footprints, but which may be more difficult to locate precisely (16) . It is commonly believed that complete analysis of the sequence selectivity of a DNA ligand requires the use of a variety of footprinting probes. Therefore, we report a comparative study employing a number of different DNA cleaving agents (DNAase I, DNAase II, micrococcal nuclease and MPE-Fell) and using different restriction fragments.
MATERIALS AND METHODS

Chemicals and Biochemicals
Full details of the synthesis of Thia-Net together with complete spectral and analytical characterization are reported elsewhere (15) . Netropsin was a gift from Professor Federico Arcamone (Farmitalia, Milan, Italy). Stock solutions of the drugs were prepared in water.
pBR322 and sonicated calf thymus DNA, Hind III, EcoRI, DNAase II and micrococcal nuclease enzymes were obtained from Pharmacia. DNAase I was purchased from Sigma Chemical Co. The plasmid DNA pBS was from Stratagene (La Jolla, CA. 
Methods
DNA restriction fragments employed for enzymatic cleavage
Three DNAs of different base composition, (i) the 160 bp tyr T DNA fragment, (ii) a 117 bp and (iii) a 253 bp DNA fragment from plasmid pBS were used in the nuclease cleavage studies. The tyr T DNA was obtained by digestion of the plasmid pKMA-98 with EcoR I and Ava I (17) . This tyr T duplex has sticky ends of unique sequence. It was labelled at the EcoR I site on the lower strand (the Crick strand) with a-[ 32 P]-dATP and reverse transcriptase, so as to give specific 3'-end labelling. The 117 mer and 253 mer were obtained from the plasmid pBS digested with Pvu WEcoR I and Pvu U/Ava I respectively. These
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Netropsin (1) Thia-Net (2) digestions also yield fragments suitable for 3'-end labelling. The detailed procedures for isolation, purification and labelling of these duplex DNA fragments were described recently (18) . DTT were added to each reaction tube. The final solutions contained 100 fM DNA base pairs, 10 mM Tris, 20 mM NaCl, 10 nM MPE-Fe(II), 2.5 mM DTT and 8, 16 or 78 /iM of ligand.
Enzymatic digestion conditions
Reactions were run at room temperature for 15 min and then stopped by freezing at -70°C. The solutions were then lyophilized and resuspended in formamide loading buffer (24) prior to gel electrophoresis. The procedures used for gel electrophoresis, autoradiography, densitometry, and data processing were described recently (18) . It is worth re-stating here that DNAase I products carry a 5'-phosphate and migrate in phase with guanine markers during electrophoresis. DNAase II (19) and MNase (21) products carry a 5'-hydroxyl and migrate 0.3-1.5 bonds more slowly than guanine markers, the difference in mobility being more marked with the shorter chains.
RESULTS
DNAase I footprinting
Experiments were carried out using all three DNAs having different arrangements of base pairs. For each DNA fragment, the products of digestion by DNAase I in the absence and presence of netropsin (1) and Thia-Net (2) were resolved by polyacrylamide gel electrophoresis. A typical autoradiogram of a DNAase I footprinting gel is illustrated in Figure 2 . Differences between the control lanes and those for the tested drugs can be clearly seen. Areas of decreased intensity (i.e. footprints) in ligand-containing lanes relative to ligand-free lanes reflect cleavage inhibition due to ligand bound to specific sequences of DNA. Densitometric analysis of the different patterns permits estimation of location and relative strength of binding at particular DNA sites. Figure 3 shows the differential cleavage plots obtained with the three DNA fragments in the presence of 10 nM netropsin and 50 /iM Thia-Net. The dips in the plot (negative values) indicate sites of drug protection from DNAase I cleavage, whereas peaks (positive values) indicate regions of drug-induced enhancement of cleavage. We will consider the results obtained with each fragment in turn. (Fig. 3, panel A) . With 10/iM netropsin five major sites of drug protection can be discerned at base positions 46, 65, 83, 110 and 128 (respectively sites 1,2, 3, 4 and 5). These protected zones extend for 6-8 bases. As expected, all five of these netropsin-protected regions are situated in AT-rich sequences of the DNA. Adjoining these protected sites are regions where the DNAase I cutting rate has been substantially enhanced relative to the control. These regions of relatively enhanced cleavage always occur in runs of C or G, as for example at positions 72-78, 94-101 and 114-118on this DNA. With the thiazole analogue 2, it can be seen (i) that 2 produces weaker protection from DNAase I cutting than does 1; and (ii) that the pattern of enhancement between nucleotide positions 80 and 135 is virtually identical for 2 and 1. These regions include netropsin binding sites 3, 4 and 5. The binding site 1 observed for 1 (around position 46) is practically non-existent for 2. More interesting is an examination of the footprints at location 50-75 on this tyr T DNA. The site 2 of netropsin binding between position 62 -68 is not recognized by compound 2, which seems in contrast to bind to two sites flanking the netropsin-binding site 2. These sites correspond to the sequences 3'-GAGTTG and 3'-AATGTC, i.e. to mixed sequences with a tendency to alternation of pyrimidines and purines. These sequences are weakly protected from DNAase I cleavage by compound 2 while the same sequences are overcut in the presence of 1. This first experiment suggests that 2 can accommodate AT-rich netropsin binding sites but can also accept binding sites containing GC base-pairs. The 117 bp DNA fragment (Fig.3, panel B) . With this DNA there is practically no concentration dependence in the binding since 10 /*M and 50 /*M 2 were found to affect the DNAase I digestion pattern more or less similarly. The netropsin binding sites around positions 20 and 85 are also filled by compound 2. These sites contain alternating AT steps. With this DNA fragment, netropsin binds to two other sites around positions 43 and 62 corresponding to the sequences 3'-AAAA (42-45) and 3'-TTTT (63-66) (a 3'-shift by 1 -2bp has been allowed for due to the bias introduced by the enzyme cutting). Compound 2 does not recognize these two sites and a large enhancement of DNAase I cleavage is evident around position 60. It is thus likely that 2 does not bind to runs of purely A or T. The sequences 3'-CCC (60-62), 3'-GGG (67-69), 3'-CCGC (71-74), 3'-GGGG (78-80) and 3'-GCGG (89-92) on this 117 mer are not protected from cleavage but are often overcut, i.e. not accepted as binding sites for 2. Thus, it seems obvious that compound 2 is not a GCspecific minor groove binder. This observation is fully confirmed by the results obtained with other DNA fragments and enzymes (Table I) . With 2, a clear protected site is observed at position 46-50, i.e. at the sequence 3'-TGTTG, a sequence not particularly well recognized by netropsin. Thus, this second set of experiments confirms that compound 2 can accommodate ATrich sites similar to those detected with netropsin as well as new sites containing G and/or C bases. Moreover it shows that runs of oligo(dA) • (dT) are not favoured.
The tyr T DNA fragment
The 253 bp DNA fragment (Fig. 3, panel C) . Illustrated in Fig. 2 are gels snowing the DNAase I footprinting patterns determined with 1 and 2 on the 253 bp DNA fragment. A clear specific pattern of blockage can be discerned, chiefly centred around position 61 for compound 2. With this thiazole analogue a total of four major protected regions can be identified, located around positions 40, 61, 83 and 108 (sites 1, 2, 3 and 4 respectively) . The size of these protected sites varies considerably from 6-7 bp to more than 12 bp, though the latter may well represent several overlapping binding sites. The densitometric analysis was limited to the regions of the gel where the bands are well separated. However, two additional sites can be discerned from the gaps in the gels near positions 130 and 150 (Fig. 2) . They lie beyond the range of accurate densitometric analysis but are clearly visible at the top of the autoradiograph.
Careful analysis of each lane of the gel in Fig. 2 
Regions where the cutting is enhanced in the presence of 2 compared with the control are also apparent. 3'-shift of 1 -2 bp still has to be allowed for). It is interesting to note that with 25 fiM compound 2 these two sites are filled to more or less the same extent while with 50 ^M 2 the second subsite (3'-ATAGG) is more protected, thus ostensibly preferred. Site 3 (76-88) can also be divided into two subsites of respective sequences 3'-ATTAG (a site also recognized by netropsin) and 3'-TACCAGTA (where protection occurs only with 2). Here again, raising the concentration from 25 /M to 50 /tM results in a slightly greater preference for the second sequence 3'-TA-CCAGTA rather than the first one 3'-ATTAG. Binding to ATrich sites containing GEC steps seems to be preferred to clusters consisting simply of alternating AT.
More interesting are the details of analysis of the primary sites 1 (37-44) and 2 (54-67) identified with compound 2. We can attribute the site 1 to the sequence 3'-AACAAGG. This site partially overlaps a netropsin binding site of sequence 3'-AAAAC. This observation supports our previous finding that 2 does not readily accept runs of A as binding sites but prefers sequences of alternating base composition. The conclusion is further confirmed by inspection of the region 47-50 (3'-AAAT) in the 253 mer which corresponds to one of the strongest binding sites for netropsin but corresponds to a region of enhanced cleavage with compound 2.
Detailed analysis of the site 2, 3'-CCCAATTAAAGCTC (55 -68), is difficult because of its large size. This impressive site, which is by far the preferred binding site of compound 2, undoubtedly corresponds to an overlap of at least two or three binding subsites. By contrast, netropsin only recognizes the central region of this sequence, i.e. 3'-TTAA.
Other complementary experiments were performed with DNAase II and micrococcal nuclease in order to elucidate the determinants of sequence recognition and to probe more accurately the exact nature of the various binding sites.
Micrococcal Nuclease Footprinting
Micrococcal nuclease (MNase) digestion patterns for the tyr T DNA fragment (Crick strand) measured in the presence and absence of 2 were examined and subjected to computation to produce the cleavage map presented in Fig. 4 . Bands in the digests were readily assigned on the basis of the known selectivity of this enzyme for cutting pA and pT bonds (25) . Netropsin binding sites on this DNA fragment have previously been located by MNase footprinting (21) . The enzyme displays a notably greater activity towards alternating AT runs compared with homopolymeric runs of A or T. This property makes it a useful tool for assessing the selectivity of drugs like netropsin 1 and its thiazole analogue 2 which bind to AT-rich regions of the DNA. MNase is a smaller enzyme than DNAase I and is known to recognize single strands of the DNA double helix.
With the Crick strand of the tyr T fragment and DNAase I, we had observed three major sites which were recognized by both 2 and netropsin. These three sites are also detected by the (Fig. 6) . A direct comparison between 1 and 2 can be made from the corresponding differential cleavage plots shown in Fig.5 (Panel B) . Here the densitometric analysis is limited to about 130 bp; the top of the gel could not be finely scanned although some other marked differences between 1 and 2 were evident in the region of the longer DNA fragments; for example, 1 induces cutting around position 140, but not 2 (Fig.6) . Strong DNAase II cleavage is evident around positions [43] [44] [45] [46] [47] [48] [49] [50] [112] [113] [114] [115] [116] and 126-128 with 2 but not with 1. The completely different patterns of DNAase II cleavage in the presence of netropsin and Thia-Net, emphasised in Fig. 5B , highlight the marked difference between their DNA sequence recognition properties. One of the most significant observations is that the sequence 3'-GAAAT (46-50), monitored by both DNAase I and DNAase II as a specific recognition site for 1, is not recognized as a binding site by 2. In addition, DNAase II reveals the existence of a strong binding site for compound 2 around position 30, at the sequence 3'-CGTACGT, a region of perfectly alternating pyrimidinepurine nucleotides. This site is not protected by netropsin. DNAase II also reveals other binding sites for compound 2 around positions S6(3'-CAGTAT) and 101 (3'-CACA), still in sequences of alternating pyrimidine-purine.
We now consider the location 54-67, by far the strongest binding site of compound 2 detected with DNAase I (see Fig. 2 ). This site is about 14 bp in length and we originally postulated the involvement of three subsites, 3'-CCCAA, 3'-TTAA (the only one recognized by 1) and 3'-AGCTC. With DNAase II as cleaving agent, this site is also more evidently protected by 2 than by 1. Because of the smaller size of DNAase II compared with DNAase I, the size of this composite binding site can be more precisely defined and it seems to contain 12 bases extending from nucleotide positions 56 to 67. It appears likely, in fact, that an overlap of two sites rather than three sites occurs in this zone. The sequence 3'-TAAAG in this site is well protected by 2 but not by 1. Interestingly, the sequence 3'-GAAAT in the same fragment (46-50) is only recognized by 1 and not by its thiazole analogue 2.
MPE-Fe(II) Footprinting
Experiments were carried out using the EcoRl-HindUl DNA restriction fragment from pBR322 which has been used for many previous drug-binding studies with this reagent (10-14) . The rationale behind this experiment is that the use of small DNAcleaving radical species (i.e. OH-generated by the metal complex) should allow more accurate estimation of the drug binding site size. Moreover, DNA cleavage by MPE-Fe is by far less sequence specific than DNAase I and so should give better definition of each binding site, perhaps allowing the identification of individual closely spaced drug binding sites.
The location and size of binding sites for 1 and 2 were measured on the basis of the positions of the maxima of Figure 6 . DNAase n digestion patterns of the 253bp DNA fragment in the absence (cont) and presence of various concentrations of netropsin or Thia-Net as specified above the relevant lanes. Other details as for Fig. 2 . asymmetric inhibition patterns generated by the ligands on opposite strands (26) . The relative binding site sizes may be deduced from the footprints of the ligands shown in the form of histograms in Fig. 7 .; the analysis extends from nucleotide positions 4250 to 4325 of plasmid pBR322. With this DNA fragment, the thiazole ligand 2 gives weak footprints compared to netropsin. At low drug/DNA molar ratio r' (<0.16) no footprints are observed with 2 whereas 1 gives strong footprints, confirming the lower affinity of 2 for DNA compared to 1 (1, K a =2.9xl0 5 M-'; 2, 1^= 1.2x10* M" 1 , for calf thymus DNA) (15) . However, clear footprints were observed at higher drug/DNA ratios. These experiments confirm that 2 is broadly AT selective in sequence preference since the footprints are 
DISCUSSION
The crystal structure of a netropsin-oligonucleotide complex (27) suggested that replacement of the 3-methine group of its pyrrole rings by a suitable heteroatom that can accept a hydrogen bond from the 2-NH 2 of guanine could lead to compounds with altered sequence preference compared to the strict AT-selectivity of netropsin. Accordingly, several lexitropsins or information reading oligopeptides have been developed having imidazole (9) (10) (11) (12) (13) (14) , furan (28, 29) , pyridine (30) , thiazole (15, (31) (32) (33) (34) and triazole (35) in place of one or more of the N-methylpyrrole units in netropsin and distamycin. Most of these resulting compounds were shown to accept GC base pairs with consequent altered sequence preference. That is clearly the case with the new analogue reported here.
Moreover, the present results show that the limitations imposed by the sequence and structural specificity of a particular cleavage reagent can be eliminated, or at least diminished, by using several different cutting probes. This combined approach, using DNAase I, DNAase II, MNase and MPE-Fe(II) permits a substantially more complete and accurate comparison between netropsin (1) and its synthetic thiazole-containing derivative (2) than would be possible with any one reagent alone.
In common with observations drawn from earlier studies we find that enzymatic probes are more sensitive but that MPE is more accurate in determining the actual site size (36) . This is especially true for Thia-Net which exhibits clear sequencespecificity but whose overall DNA affinity is relatively poor. In this case, the extreme sensitivity of DNAase I was particularly useful compared to MPE which probably competes too successfully with the ligand, yielding less easily discernible footprints. Other useful conclusions emerge concerning the use of the endonucleases MNase and DNAase II. Because of their high sequence specificity, they are rarely used and often considered as poor footprinting reagents. They have been tested mostly against AT-specific ligands (7, 21, 37, 38) . We find that these enzymes can, under the right circumstances, yield extremely interesting complementary information in the case of non-strictly AT-specific ligands; in some ways they are particularly well adapted for footprinting lexitropsins.
The results obtained from footprinting with the various cleaving agents correlate well. In broad terms, Thia-Net (2) retains the preference of netropsin for binding to AT-rich regions of the DNA. However, it is obvious that there exist significant differences between their sequence-recognition properties. The two minor groove binders differ principally in two respects. Firstly, binding to homooligomeric runs of a single base (regardless of which one) is strongly disfavoured by Thia-Net but not by netropsin. Secondly, Thia-Net can accept at least one internal GC base pair in contrast to netropsin. There are clear indications that compound 2 actually binds preferentially to certain AT-rich clusters containing a G or C nucleotide, particularly in sequences where there is an alternating pyrimidine-purine motif.
Netropsin, by virtue of its biscationic nature, binds more strongly to homopolymeric (dA)-(dT) sequences than to alternating (dA-dT) sequences where higher electronegative potential exists in the minor groove of DNA. However, the new compound containing two thiazole units having N facing the floor of the minor groove does not show any sign of binding to homo(dA) • homo(dT) sequences. Probably this is an indication of the ligand's requirement for GC bases or alternating AT sequences for binding. The difference in sequence selectivity of binding between netropsin and compound 2 plausibly derives from a different disposition of their respective hydrogen-bonding groups. It should be noted also that whatever the DNA-cleaving agent used (enzyme or OH-radicals), numerous sites of marked enhanced cleavage are observed. These enhanced cleavages, mostly located in GC-rich regions (/. e. away from the binding sites), likely arise from a redistribution of the cutting agent along the DNA (39) . Enhanced cleavages could also derive from drug-induced DNA structural changes, as observed with intercalating agents (18, 40) . But in the present case this hypothesis is unlikely because minor groove binders are known to affect the conformation of the DNA backbone only weakly (2A reduction of the groove width and bending of the helix by about 8° per drug molecule) (27, 41) .
It has been shown by footprinting and 2D-NMR studies that a bis-imidazole lexitropsin bearing two cationic charges, otherwise structurally related to netropsin, retains a preference for AT sequences while the corresponding monocationic bisimidazole lexitropsin related to distamycin does not (10, 11, 42) . It is plausible that for similar reasons of electrostatic charge our new thiazole compound binds to AT sequences like its parent molecule, and occasionally accepts an internal GC base pair.
To sum up, the new compound that we designed to exhibit altered sequence preference with a shift from AT towards GC base pairs effectively behaves differently from netropsin. It binds to discrete sites containing 4 or 5 base pairs with occasional acceptance of an internal GC base pair, almost certainly in the minor groove of DNA. However, its biscationic nature probably imposes a bias due to the electrostatic potential properties of the receptor (43) which favour the ligand reading alternating AT sequences.
Future design of GC-reading oligopeptides will demand, among other things, a more careful consideration of the notions of geometrical fitting to DNA, hydrogen bonding capabilities and some measure of the overall electronic properties of the DNAinteracting species (44, 45) . New generations of lexitropsins in which the amide linkage between the N-methylpyrrole units of netropsin will be replaced by shorter linkers are currently under development. On the basis of molecular modelling studies, and taking into account the parameters cited above, two different ways of shortening the netropsin backbone have been proposed. In one the CO or NH moiety of the amide bond would be eliminated (yielding 'isolexins') (46) . In another the amide bond would be replaced by a C=C double bond (yielding 'vinylexins') (47) . The idea is that grafting one or other of these novel design features on to the lexitropsin concept (i.e. introducing hydrogen-bond acceptors together with modification of the interunit linkage) should allow a correct synchronous meshing with base pairs along the floor of the minor groove of DNA.
